His scientific interests lie mostly in Hepatitis C virus, Immunology, Internal medicine, Virology and Hepatitis C. His Hepatitis C virus research includes elements of Coinfection and Interferon. In most of his Immunology studies, his work intersects topics such as Viral evolution.
His Internal medicine study frequently draws connections to adjacent fields such as Gastroenterology. His study looks at the relationship between Virology and fields such as Epitope, as well as how they intersect with chemical problems. Raymond T. Chung works mostly in the field of Hepatitis C, limiting it down to topics relating to Ribavirin and, in certain cases, Alpha interferon and Interferon alfa.
Internal medicine, Hepatitis C virus, Immunology, Virology and Hepatitis C are his primary areas of study. His work deals with themes such as Gastroenterology and Ribavirin, which intersect with Internal medicine. His study in Gastroenterology is interdisciplinary in nature, drawing from both Fibrosis, Nonalcoholic fatty liver disease, Liver transplantation and Cohort.
The concepts of his Hepatitis C virus study are interwoven with issues in Chronic infection and Transplantation. Many of his studies on Immunology apply to Disease as well. Hepatitis C is closely attributed to Intensive care medicine in his work.
His primary scientific interests are in Internal medicine, Gastroenterology, Cirrhosis, Liver disease and Hepatitis C virus. Hepatitis C, Transplantation, Nonalcoholic fatty liver disease, Hepatocellular carcinoma and Cohort are among the areas of Internal medicine where the researcher is concentrating his efforts. He has included themes like Hepatitis B, Prospective cohort study, Interquartile range and Liver biopsy in his Gastroenterology study.
His Cirrhosis research is multidisciplinary, relying on both Liver cancer and Acute kidney injury. His Liver disease study incorporates themes from Chronic liver disease and Liver transplantation. His Hepatitis C virus study falls within the topics of Immunology and Virus.
His scientific interests lie mostly in Internal medicine, Gastroenterology, Hepatitis C, Liver disease and Liver transplantation. His Gastroenterology research is multidisciplinary, incorporating perspectives in Interquartile range, Biopsy, Liver biopsy, Acute kidney injury and Aspirin. His Hepatitis C study combines topics from a wide range of disciplines, such as Hemodialysis, Patient education, Hepacivirus, Kidney transplantation and Antiviral treatment.
His research in Liver transplantation intersects with topics in Hepatology, MEDLINE and Intensive care medicine. He interconnects Interferon and Hepatitis C virus in the investigation of issues within Epigenetics. His Odds ratio study integrates concerns from other disciplines, such as Advance care planning and Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States
George Ostapowicz;Robert J. Fontana;Frank V. Schioødt;Anne Larson.
Annals of Internal Medicine (2002)
A role for hepatitis C virus infection in type II cryoglobulinemia.
Vincent Agnello;Raymond T. Chung;Lee M. Kaplan.
The New England Journal of Medicine (1992)
Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
F. Lechner;D. K. H. Wong;P. R. Dunbar;R. Chapman.
Journal of Experimental Medicine (2000)
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression.
Jodie L Babitt;Franklin W Huang;Diedra M Wrighting;Yin Xia.
Nature Genetics (2006)
Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons.
Raymond T. Chung;Janet Andersen;Paul Volberding;Gregory K. Robbins.
The New England Journal of Medicine (2004)
Hepatitis C Virus Prevalence among Patients Infected with Human Immunodeficiency Virus: A Cross-Sectional Analysis of the US Adult AIDS Clinical Trials Group
Kenneth E. Sherman;Susan D. Rouster;Raymond T. Chung;Natasa Rajicic.
Clinical Infectious Diseases (2002)
A TALEN Genome-Editing System for Generating Human Stem Cell-Based Disease Models
Qiurong Ding;Youn-Kyoung Lee;Esperance Anne Kreek Schaefer;Derek Tilghman Peters.
Cell Stem Cell (2013)
The epigenetic landscape of T cell exhaustion
Debattama R. Sen;James Kaminski;R. Anthony Barnitz;Makoto Kurachi.
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant.
Zachariah DeFilipp;Patricia P. Bloom;Mariam Torres Soto;Michael K. Mansour.
The New England Journal of Medicine (2019)
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
Raymond T. Chung;Marc G. Ghany;Arthur Y. Kim;Kristen M. Marks.
Clinical Infectious Diseases (2018)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: